More stories

H&S

COVID-19 vaccines found to be highly effective after a single dose

By Alexandra Holmes | April 28, 2021

Researchers note that even after just a single dose, these vaccines can be anywhere from 50 to 75 percent effective in preventing COVID-19 infection.

---

H&S

U.Va. Health leaders reflect on one year of COVID-19

By Swati Srivastava and Astha Kulshrestha | April 27, 2021

This time last spring, COVID-19 first hit the University and caused its normal operations to shut down. Since then, U.Va. Health has taken several actions in a continuous and evolving response to the pandemic.

---

H&S

Medical professionals emphasize the role human connection plays in their daily lives

By Abigail Challas | April 25, 2021

Physicians are often faced with tough circumstances and emphasize the role good connection and quality relationships play throughout their careers, from residency to present day.

---

H&S

Home-monitoring system BESI-C aims to reduce cancer pain

By Samuel Opuni | April 25, 2021

A smart health home-monitoring system that aims to reduce cancer pain by detecting it before it arises and helps healthcare workers effectively intervene.

---

H&S

U.Va. engineering students establish Women in Cybersecurity chapter

By Jacob Woodford | April 12, 2021

Dianna Damenova and Connie Zhang establish Women in Cybersecurity chapter to provide opportunities for female students to thrive within STEM fields.

---

H&S

How pandemic fatigue impacts student wellness through a year of the COVID-19 pandemic

By Brigitte Meyer | April 7, 2021

Beyond just demotivation, students have experienced significant changes to overall mental health and wellness due to added stress and the disruption of normalcy.

---

H&S

U.Va. health care professionals educate public on COVID-19 vaccines at virtual town hall

By Alina Jiang | April 2, 2021

U.Va. health care professionals spoke Tuesday in a virtual town hall to answer the public’s questions about the COVID-19 vaccines.

---

H&S

U.Va. enters NIH study examining effects of COVID-19 vaccine on virus infection, transmission

By Anika Iyer | March 31, 2021

The study will use the data collected to predict how well the vaccine can prevent asymptomatic infection and the transmission of the virus to others.

---

H&S

Professors examine unexpected success in stock market during COVID-19 pandemic

By Lucie Rutherford | March 30, 2021

The unexpected success of the market can be attributed to a small group of ‘stay-at-home’ stocks such as Zoom and Amazon, which have become a significant part of the S&P 500.

---

H&S

Pandemic adds hurdles to equitable internet access

By Erica Szymanski | March 23, 2021

Over half of Americans considered internet access “essential” during the pandemic.

---

H&S

University students awarded in NASA’s 2020 BIG Idea Challenge

By Samuel Opuni | March 22, 2021

The team project focused on powering devices in dark areas on the moon that receive no sunlight by using lasers to transmit energy to rovers.

---

H&S

Three COVID-19 variants present globally, two currently identified in Virginia

By Abigail Challas | March 22, 2021

A select number of mutations are advantageous to the virus and increase the virus’s fitness, allowing it to spread more quickly amongst the population they infect. 

---

H&S

New interatrial shunt device holds promise for heart failure patients

By Swati Srivastava | March 21, 2021

A new device developed by two heart device manufacturers — called the interatrial shunt — is currently being tested in clinical trials at several sites nationwide, including at U.Va. Health. If the results of the trial prove promising, these devices could help ease symptoms in heart failure patients and increase their quality of life.

---

H&S

Antibody cocktail provides short-term immunity against COVID-19 infections

By Brightney Varghese | March 13, 2021

U.Va. Health is participating in clinical trials to test an antibody cocktail which is showing to providing short-term immunity against symptomatic COVID-19 infections.